Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Metronidazole Benzoate Granules vs Flagyl Tablets
NCT02402283Phase 1Completed
- Sponsor
- Verisfield
- Start
- May 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of metronidazole benzoate in bacterial infection and protozoal infection (2 arms), sponsored by Verisfield. Primary endpoints: Area Under the Plasma Concentration-Time Curve from Zero to Time t at 48 hours and Maximum Plasma Concentration at 48 hours. Started May 2015; status: completed.
02
Drugs
metronidazole benzoate
03
Conditions
bacterial infectionprotozoal infection
Beyond the preview
Go deeper on NCT02402283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402283.